Pharmacologic Intervention for Attention-Deficit Hyperactivity Disorder in Preschoolers
- 9 November 2012
- journal article
- current opinion
- Published by Springer Nature in Pediatric Drugs
- Vol. 15 (1) , 1-8
Abstract
Pharmacologic intervention for attention-deficit hyperactivity disorder (ADHD) in preschool children is a controversial issue. Non-pharmacologic interventions (psychosocial and restricted dietary interventions) have been shown to benefit oppositional, non-compliant, aggressive and disruptive, as well as hyperactive and inattentive behaviors in preschoolers with ADHD and other disruptive behavior disorders. However, not all families have access to non-pharmacologic interventions or prefer them. The Preschool ADHD Treatment Study recently provided evidence of benefit with immediate-release methylphenidate; however, effect sizes were small to moderate and preschoolers had a high rate of adverse effects and a unique adverse effect profile. Furthermore, no information is available about long-term safety and effects of psychopharmacologic agents on the rapidly developing brains of preschoolers. Based on current evidence and guidelines, a careful trial with psychopharmacologic agents is indicated to treat ADHD in preschoolers if there is no improvement with behavior therapy and the preschoolers continue to exhibit significantly impaired hyperactive and inattentive symptoms. Preschoolers should be monitored closely for adverse effects and tried off medications after 6 months to assess the need for ongoing psychopharmacologic intervention. Further research is needed to identify predictors and moderators of response to guide individualized/optimal treatment options for ADHD in preschoolers.Keywords
This publication has 59 references indexed in Scilit:
- A Double-Blind, Placebo-Controlled Study of Atomoxetine in Young Children With ADHDPediatrics, 2011
- Combining Parent and Child Training for Young Children with ADHDJournal of Clinical Child & Adolescent Psychology, 2011
- Mental Disorders in Five-Year-Old Children With or Without Developmental Delay: Focus on ADHDJournal of Clinical Child & Adolescent Psychology, 2010
- Randomized, Placebo-Controlled, Crossover Study of Methylphenidate for Attention-Deficit/Hyperactivity Disorder Symptoms in Preschoolers with Developmental DisordersJournal of Child and Adolescent Psychopharmacology, 2009
- Prospective, Naturalistic, Pilot Study of Open-Label Atomoxetine Treatment in Preschool Children with Attention-Deficit/Hyperactivity DisorderJournal of Child and Adolescent Psychopharmacology, 2009
- Psychostimulant Treatment and the Developing Cortex in Attention Deficit Hyperactivity DisorderAmerican Journal of Psychiatry, 2009
- No elevated genomic damage in children and adolescents with attention deficit/hyperactivity disorder after methylphenidate therapyToxicology Letters, 2009
- Psychopharmacological and Other Treatments in Preschool Children with Attention-Deficit/Hyperactivity Disorder: Current Evidence and PracticeJournal of Child and Adolescent Psychopharmacology, 2008
- Synaptophysin and postsynaptic density protein 95 in the human prefrontal cortex from mid-gestation into early adulthoodNeuroscience, 2007
- Dopamine Receptor Activation Modulates GABA Neuron Migration from the Basal Forebrain to the Cerebral CortexJournal of Neuroscience, 2007